CNTX - CIK 0001842952
The table below shows Context Therapeutics Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $54.53M | $76.94M | $83.52M | $89.35M | $84.80M | $101.54M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $58.52M |
| $79.06M |
| $86.95M |
| $92.73M |
| $86.07M |
| $102.70M |
| Property, plant & equipment | $62.23K | $33.72K | $37.79K | $41.85K | $14.89K | $10.39K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $58.86M | $79.23M | $87.15M | $92.97M | $86.33M | $102.71M |
| Accounts payable | $2.47M | $2.72M | $2.40M | $1.00M | $1.03M | $611.51K |
| Total current liabilities | $6.53M | $6.04M | $4.56M | $1.90M | $2.33M | $1.60M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $6.66M | $6.06M | $4.61M | $1.98M | $2.47M | $1.60M |
| Retained earnings | -$139.58M | -$117.88M | -$108.18M | -$99.36M | -$91.44M | -$73.98M |
| Total equity | $52.20M | $73.17M | $82.54M | $90.98M | $83.86M | $101.10M |